Guardant Health Inc

NAS:GHHealthcareNASDAQ:NBINASDAQ:NQUSMG

$157.88−0.45%At closeAt close · Tue 20 Oct · ≈ AED 579.81 · Market cap $21.19B · Next earnings Wed 28 Oct · Extended $158.20 +0.20%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	67.7%	67.1%	65.2%	59.7%	60.8%	64.5%	—	—
Operating margin	−88.9%	−110.0%	−121.1%	−100.1%	−60.0%	−44.4%	−44.4%	+0.0 pts
Net margin	−88.5%	−108.6%	−145.6%	−85.0%	−59.0%	−42.4%	−42.4%	+0.0 pts
EBITDA margin	−78.5%	−96.2%	−136.8%	−76.8%	−52.8%	−38.1%	—	—
Return on equity	−19.5%	−62.9%	−1,087.7%	−302.1%	312.5%	419.2%	419.2%	+0.0 pts
Return on assets	−11.2%	−18.4%	−40.7%	−26.8%	−29.4%	−20.7%	−20.7%	+0.0 pts
Return on capital employed	−11.6%	−20.4%	−38.4%	−35.7%	−35.2%	−25.5%	—	—
Debt / equity	0.7×	2.1×	22.8×	8.5×	−9.6×	−17.2×	−17.2×	+0.0%
Debt / assets	37.6%	62.3%	85.0%	75.8%	89.9%	84.9%	—	—
Interest coverage	−53.5×	−159.5×	−211.2×	−219.1×	−171.9×	−112.0×	—	—
Current ratio	28.3×	5.7×	6.2×	6.5×	4.7×	4.8×	4.8×	+0.0%
Quick ratio	27.9×	5.6×	5.9×	6.2×	4.4×	4.6×	—	—
Cash ratio	12.5×	2.5×	0.7×	5.5×	2.3×	1.2×	1.2×	+0.0%
Asset turnover	0.1×	0.2×	0.3×	0.3×	0.5×	0.5×	—	—
Inventory turnover	4.1×	4.0×	3.0×	3.7×	4.1×	4.1×	—	—
Receivables turnover	5.4×	3.8×	4.6×	6.4×	6.7×	7.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—